Information sheet for drug distributors : albendazole and diethylcarbamazine /cProgramme to Eliminate Lymphatic Filariasis (PELF)
WHO Programme to Eliminate Lymphatic Filariasis. (2004). Information sheet for drug distributors : albendazole and diethylcarbamazine /cProgramme to Eliminate Lymphatic Filariasis (PELF). Geneva : World Health Organization. http://www.who.int/iris/handle/10665/69047
Gov't Doc #WHO/CDS/CPE/CEE/2004.43
MetadataShow full item record
Showing items related by title and MeSH subject.
A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp. / V.Y. Belizario ... [et al.] Belizario, V. Y; Amarillo, M. E; De Leon, W. U; De los Reyes, A. E; Bugayong, M. G; Macatangay, B. J. C (2003)
Fifth Annual Workshop on Filariasis Elimination in the Pacific, Nadi, Fiji, 22-26 September 2003 : report World Health Organization. Regional Office for the Western Pacific ((WP)MVP/ICP/MVP/1.2/001-E, 2003)
Baqai, R.; Zuberi, S.J.; Qureshi, H.; Ahmed, W.; Hafiz, S. (2001)Albendazole and metronidazole were compared in 68 patients diagnosed positive for giardiasis. Albendazole 1200 mg, one dose was given to 24 patients, albendazole 400 mg twice a day for 3 days was given to 23 patients, and metronidazole 400 mg 3 times a day for 5 days to 21 patients. Response to therapy was monitored by clinical examination and analysis of fresh faecal samples on days 0, 3, 7 and 10. Response to the single dose of albendazole was 55%, to the divided dose of albendazole 70%, and to metronidazole 84%. The results show that albendazole, ...